Paul William Finn
Paul William Finn
Oxford Drug Design Limited, University of Buckingham, Affinity Drug Design
Verified email at oxforddrugdesign.com
TitleCited byYear
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
N Khan, M Jeffers, S Kumar, C Hackett, F Boldog, N Khramtsov, X Qian, ...
Biochemical Journal 409 (2), 581-589, 2008
6812008
Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101
JA Plumb, PW Finn, RJ Williams, MJ Bandara, MR Romero, CJ Watkins, ...
Molecular cancer therapeutics 2 (8), 721-728, 2003
3652003
Quantitative proteomic analysis of post-translational modifications of human histones
HC Beck, EC Nielsen, R Matthiesen, LH Jensen, M Sehested, P Finn, ...
Molecular & Cellular Proteomics 5 (7), 1314-1325, 2006
1882006
Pharmacophore discovery using the inductive logic programming system Progol
P Finn, S Muggleton, D Page, A Srinivasan
Machine Learning 30 (2-3), 241-270, 1998
1621998
Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
N Steele, P Finn, R Brown, JA Plumb
British journal of cancer 100 (5), 758, 2009
1342009
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
A Amolins, V Andrianov, RM Bokaldere, K Dikovska, JES Duffy, PW Finn, ...
US Patent 7,880,020, 2011
105*2011
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
A Amolins, V Andrianov, RM Bokaldere, K Dikovska, JES Duffy, PW Finn, ...
US Patent App. 12/983,971, 2011
101*2011
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
A Amolins, V Andrianov, RM Bokaldere, K Dikovska, JES Duffy, PW Finn, ...
US Patent 7,569,724, 2009
100*2009
Rapid: Randomized pharmacophore identification for drug design
PW Finn, LE Kavraki, JC Latombe, R Motwani, C Shelton, ...
Computational Geometry 10 (4), 263-272, 1998
871998
RAPID: Randomized pharmacophore identification for drug design
PW Finn, LE Kavraki, JC Latombe, M R, C Shelton, ...
Computational Geometry: Theory and Applications 4 (10), 263-272, 1998
871998
Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
CJ Watkins, MR Romero-Martin, KG Moore, J Ritchie, PW Finn, I Kalvinsh, ...
US Patent 6,888,027, 2005
842005
Carbamic acid compounds comprising an ether linkage as HDAC inhibitors
CJ Watkins, MR Romero-Martin, PW Finn, I Kalvinsh, E Loza, D Lolya, ...
US Patent 6,960,685, 2005
832005
Carbamic acid compounds comprising an ether linkage as HDAC inhibitors
RM Bokaldere, JES Duffy, PW Finn, CJ Harris, I Kalvinsh, D Lolya, E Loza, ...
US Patent 6,960,685, 2005
83*2005
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
CJ Watkins, MR Romero-Martin, KG Moore, J Ritchie, PW Finn, I Kalvinsh, ...
US Patent 7,569,724, 2009
762009
The cell cycle, chromatin and cancer: mechanism-based therapeutics come of age
F McLaughlin, P Finn, NB La Thangue
Drug discovery today 8 (17), 793-802, 2003
732003
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
CJ Watkins, MR Romero-Martin, KG Moore, J Ritchie, PW Finn, I Kalvinsh, ...
US Patent 7,569,724, 2009
712009
Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
CJ Watkins, MR Romero-Martin, KG Moore, J Ritchie, PW Finn, I Kalvinsh, ...
US Patent 6,888,027, 2005
712005
Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology
PJ Ballester, PW Finn, WG Richards
Journal of Molecular Graphics and Modelling 27 (7), 836-845, 2009
692009
ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics
MS Armstrong, GM Morris, PW Finn, R Sharma, L Moretti, RI Cooper, ...
Journal of computer-aided molecular design 24 (9), 789-801, 2010
642010
Computational approaches to drug design
PW Finn, LE Kavraki
Algorithmica 25 (2-3), 347-371, 1999
641999
The system can't perform the operation now. Try again later.
Articles 1–20